Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 12/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4731475 | 0.91 | UTS2R (0.63) | UTS2R | |
| SCHEMBL4731255 | 0.91 | UTS2R (0.56) | UTS2RNPC1 | |
| SCHEMBL4732737 | 0.90 | UTS2R (0.61) | UTS2REPHX2 | |
| SCHEMBL4731222 | 0.90 | UTS2R (0.64) | UTS2RSMN1; SMN2 | |
| SCHEMBL4730453 | 0.90 | NPC1 (0.60) | UTS2RLMNAPOLBNPC1RAB9A | |
| SCHEMBL4733409 | 0.87 | UTS2R (0.61) | UTS2RNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4733066 | 0.86 | UTS2R (0.60) | UTS2R | |
| SCHEMBL4731281 | 0.84 | UTS2R (0.62) | UTS2RNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4730712 | 0.82 | UTS2R (0.61) | UTS2RNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4729682 | 0.81 | UTS2R (0.64) | UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008057543-A2 | UII-MODULATING COMPOUNDS AND THEIR USE | ACADIA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | claimed |
| WO-2008057543-A2 | UII-MODULATING COMPOUNDS AND THEIR USE | ACADIA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | disclosed |